Linkedbio is the newly launched services provided by Lingmed. We help companies to understand and monitor China market opportunities, define the right strategies and work with the right partners

  • Linkedbio Partnering:

    Lingmed analyst team evaluates the innovative biotech products, technologies and medical devices to estimate the market size, risk & opportunities, to identify the right partner for the asset. Lingmed team will arrange partnering meetings to facilitate the direct dialogues, suggest deal structure to support deal closing

  • Linkedbio Analysis:

    Lingmed analyst team conducts desk researches and interviews to get insights on China market, we provide tailored product China market sizing analysis, deal valuation and competitive landscape reports to our clients

Latest Lingmed asset recommendation
Japanese Innovative Oncology Project —— Treating Biliary Tract Cancer, Non-Small Cell Lung Cancer, and Urothelial Carcinoma Seeking partner in Greater China (LMP2828) (Tuesday, 15 Sep 2026)
  • Project ID：LMP2828
  • Project Description：Liposomal gemcitabine- DNA polymerase inhibitor
  • Indications：Biliary tract cancer (FDA Orphan Drug Designation), Phase 1；Non-small cell lung cancer and urothelial cancer, Phase 2a
  • Partnering Needs: Actively seeking strategic partners for licensing out or co-development in Greater China
  • Company Description: LMC5001789 is a comprehensive Japanese group company with a pharmaceutical division dedicated to oncology, infectious diseases, and regenerative medicine
  • Development Stage, Mode of Administration, Partnering Needs, Company Description, Project Highlights......
Related asset recommendations
European Innovative Oncology Nuclear Medicine Project ——T-cell lymphoma Therapy Monitoring & Theragnostics Seeking partner in Greater China (LMP2826)
European Innovative CNS/Pain Project ——Treating Acute/Chronic Pain Seeking partner in Greater China (LMP2825)
Latest Lingmed monthly webinar
Advances in the Mechanism and Treatments of Parkinson's Disease, are you ready? (Wednesday, 17 Sep 2025)
Event details
  • Epidemiology of Parkinson's disease and trend analysis of disease burden
  • Research progress on the mechanism of Parkinson's disease
  • Clinical guidelines and standards for Parkinson's disease
  • Tracking of the latest global prevention & treatment strategies and technical progress of Parkinson's disease
  • Global Parkinson's disease drug BD deals tracking during the past 5 years
  • An innovative biotech roadshow
Related monthly webinars
Global development of innovative drugs for the treatment of chronic liver diseases, are you ready?
New strategies and key mechanisms for hearing loss treatment , are you ready?
General information
Product > 482
Company > 850
Deals > 391
Reports > 203
Non-confi PDF > 314